Arcutis Biotherapeutics Q3 EPS $0.06 Misses $0.12 Estimate, Sales $143.919M Beat $142.592M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings BeatsEarnings Misses
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.12 by 50 percent. This is unchanged from the same period last year. The company
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.12 by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $143.919 million which beat the analyst consensus estimate of $142.592 million by 0.93 percent. This is a 45.05 percent increase over sales of $99.219 million the same period last year.